Arrhythmia Research Technology (HRT) Posts Surprise Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/27/2026
- Equities end higher as Anthropic's IPO filing buoys AI stocks
- Anthropic files for Nasdaq IPO as revenue jumps to $16.3 billion
- Meta reverses losses to rise as investors weigh $35 billion AI funding plan
- Post-election relief ahead for markets, says Morgan Stanley
- Musk says SpaceX raised $40 billion in debt, warns of neocloud collapse
Tweet
Share
E-mailGet Alerts HRT Hot Sheet
Price: $14.36 --0%
Financial Fact:
Research and development: 24.53K
Today's EPS Names:
JBLU, SICP, OMID, More
Financial Fact:
Research and development: 24.53K
Today's EPS Names:
JBLU, SICP, OMID, More
Join SI Premium – FREE
Arrhythmia Research Technology (NYSE: HRT) reported Q3 EPS of ($0.10), $0.60 worse than the analyst estimate of $0.50. Revenue for the quarter came in at $5.23 million versus the consensus estimate of $136.4 million.
For earnings history and earnings-related data on Arrhythmia Research Technology (HRT) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- JetBlue Airways (JBLU) Misses Q3 EPS by 6c, Misses on Revenue
- Rambus (RMBS) Tops Q3 EPS by 5c, Offers Guidance
- Avidbank Holdings, Inc. (AVBH) Tops Q3 EPS by 7c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
